Chronic MH has distinct features on OCT

Article

Chronic macula holes (MHs) have distinct features compared to those of acute symptomatic MH on OCT findings.

Chronic macula holes (MHs) have distinct features compared to those of acute symptomatic MH on OCT findings, according to a paper published in Retina.

Dr C. Yun et al., Department of Ophthalmology, Korea University College of Medicine, Seoul, South Korea, retrospectively reviewed OCT images of 13 eyes of 13 patients with chronic MH and 67 eyes of 67 patients classified as controls.

Chronic MH was identified as MH observed without undergoing surgical treatment for at least a year. The OCT parameters were compared between chronic and acute MH.

The basal hole diameter did not differ when chronic MH eyes and control eyes were compared. However, the minimum hole diameter of chronic MH was larger than the control diameters. Hole height and MH index were smaller in the chronic MH group, compared to the control group.

Only the chronic MH group presented with retinal pigment epithelial atrophy and intraretinal fluid was less frequently observed, compared to the control group. The findings could be useful for identifying the differences between chronic and acute MH.

To read the abstract please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.